>

Diffusion Pharmaceuticals, Inc. reported raising $15.8M in a private placement filing on March 16, 2017

Mar 18, 2017 - RelSci Data Update
Investments

Background Information:
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
In The News:
Poster Presented at International Stroke Conference Describing Diffusion's On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke
February 11, 2019  •  GlobeNewswire
Robert R. Ruffolo, Jr. is no longer serving in their board position at Diffusion Pharmaceuticals, Inc.
January 19, 2019  •  RelSci
Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market
January 3, 2019  •  GlobeNewswire
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.